337 related articles for article (PubMed ID: 8766573)
21. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
22. T-bet is essential for the progression of experimental autoimmune encephalomyelitis.
Nath N; Prasad R; Giri S; Singh AK; Singh I
Immunology; 2006 Jul; 118(3):384-91. PubMed ID: 16827899
[TBL] [Abstract][Full Text] [Related]
23. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
24. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process.
Mix E; Ibrahim S; Pahnke J; Koczan D; Sina C; Böttcher T; Thiesen HJ; Rolfs A
J Neuroimmunol; 2004 Jun; 151(1-2):158-70. PubMed ID: 15145614
[TBL] [Abstract][Full Text] [Related]
25. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains.
Chung IY; Norris JG; Benveniste EN
J Exp Med; 1991 Apr; 173(4):801-11. PubMed ID: 1901078
[TBL] [Abstract][Full Text] [Related]
26. Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Orian JM; Keating P; Downs LL; Hale MW; Jiang X; Pham H; LaFlamme AC
Autoimmunity; 2015 Jun; 48(4):208-21. PubMed ID: 25427822
[TBL] [Abstract][Full Text] [Related]
27. Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis.
Schiffmann S; Ferreiros N; Birod K; Eberle M; Schreiber Y; Pfeilschifter W; Ziemann U; Pierre S; Scholich K; Grösch S; Geisslinger G
J Immunol; 2012 Jun; 188(11):5723-33. PubMed ID: 22544924
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
Maron R; Hancock WW; Slavin A; Hattori M; Kuchroo V; Weiner HL
Int Immunol; 1999 Sep; 11(9):1573-80. PubMed ID: 10464178
[TBL] [Abstract][Full Text] [Related]
29. [Bone marrow stromal cells transfected with ciliary neurotrophic factor gene ameliorates the symptoms and inflammation in C57BL/6 mice with experimental allergic encephalomyelitis].
Lu ZQ; Hu XQ; Zhu CS; Zheng XP; Wan DJ; Liu RY; Huang BJ; Huang WL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2355-61. PubMed ID: 20034875
[TBL] [Abstract][Full Text] [Related]
30. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis.
Chu CQ; Wittmer S; Dalton DK
J Exp Med; 2000 Jul; 192(1):123-8. PubMed ID: 10880533
[TBL] [Abstract][Full Text] [Related]
31. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis.
Jemison LM; Williams SK; Lublin FD; Knobler RL; Korngold R
J Neuroimmunol; 1993 Aug; 47(1):15-22. PubMed ID: 8104193
[TBL] [Abstract][Full Text] [Related]
33. Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.
Gaupp S; Pitt D; Kuziel WA; Cannella B; Raine CS
Am J Pathol; 2003 Jan; 162(1):139-50. PubMed ID: 12507897
[TBL] [Abstract][Full Text] [Related]
34. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice.
Butterfield RJ; Sudweeks JD; Blankenhorn EP; Korngold R; Marini JC; Todd JA; Roper RJ; Teuscher C
J Immunol; 1998 Aug; 161(4):1860-7. PubMed ID: 9712054
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
[TBL] [Abstract][Full Text] [Related]
36. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs.
Wang Z; Hong J; Sun W; Xu G; Li N; Chen X; Liu A; Xu L; Sun B; Zhang JZ
J Clin Invest; 2006 Sep; 116(9):2434-41. PubMed ID: 16906223
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.
Wensky AK; Furtado GC; Marcondes MC; Chen S; Manfra D; Lira SA; Zagzag D; Lafaille JJ
J Immunol; 2005 Feb; 174(3):1416-23. PubMed ID: 15661899
[TBL] [Abstract][Full Text] [Related]
38. Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats.
Mensah-Brown EP; Shahin A; Al Shamisi M; Lukic ML
J Neuroimmunol; 2011 Mar; 232(1-2):68-74. PubMed ID: 21109309
[TBL] [Abstract][Full Text] [Related]
39. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains.
Duong TT; Finkelman FD; Singh B; Strejan GH
J Neuroimmunol; 1994 Aug; 53(1):101-7. PubMed ID: 8051292
[TBL] [Abstract][Full Text] [Related]
40. Relapsing experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.
Lublin FD; Knobler RL; Doherty PC; Korngold R
Clin Exp Immunol; 1986 Dec; 66(3):491-6. PubMed ID: 3568447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
